- Home
- CNTA vs NBTB Comparison
CNTA vs NBTB Comparison
Compare CNTA & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- NBTB
- Stock Information
- Founded
- CNTA 2020
- NBTB 1856
- Country
- CNTA United Kingdom
- NBTB United States
- Employees
- CNTA N/A
- NBTB N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- NBTB Major Banks
- Sector
- CNTA Health Care
- NBTB Finance
- Exchange
- CNTA Nasdaq
- NBTB Nasdaq
- Market Cap
- CNTA 1.6B
- NBTB 2.2B
- IPO Year
- CNTA 2021
- NBTB N/A
- Fundamental
- Price
- CNTA $13.07
- NBTB $41.60
- Analyst Decision
- CNTA Strong Buy
- NBTB Buy
- Analyst Count
- CNTA 10
- NBTB 3
- Target Price
- CNTA $28.78
- NBTB $52.33
- AVG Volume (30 Days)
- CNTA 1.2M
- NBTB 214.3K
- Earning Date
- CNTA 08-12-2025
- NBTB 07-21-2025
- Dividend Yield
- CNTA N/A
- NBTB 3.25%
- EPS Growth
- CNTA N/A
- NBTB 17.05
- EPS
- CNTA N/A
- NBTB 3.03
- Revenue
- CNTA $15,000,000.00
- NBTB $569,473,000.00
- Revenue This Year
- CNTA N/A
- NBTB $26.51
- Revenue Next Year
- CNTA N/A
- NBTB $12.04
- P/E Ratio
- CNTA N/A
- NBTB $13.83
- Revenue Growth
- CNTA 118.88
- NBTB 13.26
- 52 Week Low
- CNTA $8.46
- NBTB $37.31
- 52 Week High
- CNTA $19.09
- NBTB $52.44
- Technical
- Relative Strength Index (RSI)
- CNTA 52.42
- NBTB 52.06
- Support Level
- CNTA $12.74
- NBTB $40.53
- Resistance Level
- CNTA $14.27
- NBTB $41.88
- Average True Range (ATR)
- CNTA 0.68
- NBTB 0.82
- MACD
- CNTA 0.11
- NBTB 0.05
- Stochastic Oscillator
- CNTA 55.99
- NBTB 63.61
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.